474PAfatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC. (25th November 2018) - Thongprasert, S; Geater, S L; Clement, D; Abdelaziz, A; Reyes-Igama, J; Jovanovic, D; Alexandru, A; Schenker, M; Sriuranpong, V; Serwatowski, P; Suresh, S; Cseh, A; et al.